Envestnet Asset Management
PTLA

Envestnet Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Envestnet Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-52,486
Closed -$374K – 3213
2020
Q1 		$374K Sell
52,486
-8,607
-14% -$107K ﹤0.01% 2445
2019
Q4 		$1.46M Buy
61,093
+1,331
+2% +$36.7K ﹤0.01% 1793
2019
Q3 		$1.6M Buy
59,762
+15,576
+35% +$437K ﹤0.01% 1675
2019
Q2 		$1.2M Buy
44,186
+4,691
+12% +$147K ﹤0.01% 1832
2019
Q1 		$1.37M Buy
+39,495
New +$1.14M ﹤0.01% 1695
2016
Q2 		– Sell
-1,288
Closed -$26K – 3163
2016
Q1 		$26K Sell
1,288
-272
-17% -$8.63K ﹤0.01% 2919
2015
Q4 		$80K Sell
1,560
-172
-10% -$8.34K ﹤0.01% 2468
2015
Q3 		$74K Buy
+1,732
New +$83.6K ﹤0.01% 2479
2014
Q4 		– Sell
-34
Closed -$1K – 2790
2014
Q3 		$1K Hold
34
– – ﹤0.01% 2685
2014
Q2 		$1K Hold
34
– – ﹤0.01% 2657
2014
Q1 		$1K Hold
34
– – ﹤0.01% 2486
2013
Q4 		$1K Buy
+34
New +$826 ﹤0.01% 2403

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Envestnet Asset Management's PTLA Position: Q2 2020 in Review

Envestnet Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 52,486 shares — an estimated $374K sold.

Envestnet Asset Management first reported a position in PTLA in Q4 2013 and held it in 12 quarters. The position peaked at $1.6M in Q3 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Envestnet Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Envestnet Asset Management sold 52,486 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $374K.
  • Envestnet Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 12 quarters.
  • Envestnet Asset Management's Portola Pharmaceuticals, Inc. position peaked at $1.6M in Q3 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Envestnet Asset Management's 13F filing for Q2 2020, filed 8 Jul 2020.